Nguyen, Lee S. http://orcid.org/0000-0002-6014-6269
Cooper, Leslie T.
Kerneis, Mathieu
Funck-Brentano, Christian http://orcid.org/0000-0003-0406-5189
Silvain, Johanne
Brechot, Nicolas
Hekimian, Guillaume
Ammirati, Enrico
Ben M’Barek, Badr
Redheuil, Alban
Gandjbakhch, Estelle
Bihan, Kevin http://orcid.org/0000-0001-6797-0237
Lebrun-Vignes, Bénédicte
Ederhy, Stephane
Dolladille, Charles
Moslehi, Javid J.
Salem, Joe-Elie http://orcid.org/0000-0002-0331-3307
Article History
Received: 11 February 2021
Accepted: 2 December 2021
First Online: 10 January 2022
Competing interests
: M.K. has received consulting fees from Sanofi, lecture fees from Bayer, a research grant from PHRC 2015 (P150921), Federation Française de Cardiologie. J.S. reports during the past 2 years the following disclosures: consulting Fees or Lecture Fees or Travel Support from AstraZeneca, Bayer HealthCare SAS, Boehringer Ingelheim France, CSL Behring SA, Gilead Science, Sanofi-Aventis France, Terumo France SAS, Abbott Medical France SAS, Stockholder of Pharmaseeds. B.B.M. has no conflict of interest regarding this work, and is currently employed by Kayrros (Paris, France). E. G. received consulting fees from consulting fees from Boston Scientific, Microport and Medtronic. J.J.M. received fees from Pfizer, Novartis, Bristol-Myers Squibb, Deciphera, Audentes Pharmaceuticals, Nektar, Takeda, Ipsen, Myokardia, AstraZeneca, GlaxoSmithKline, Intrexon, and Regeneron, and is supported by R01 HL141466. J.-E. S. has participated to BMS advisory boards. The remaining authors declare no competing interests.
: The lead author (the manuscript’s guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.